Endomyocardial Upregulation of β1 Adrenoreceptor Gene Expression and Myocardial Contractile Reserve Following Cardiac Resynchronization Therapy

Journal of Cardiac Failure

Volumn 14, Issue 2, 2008, Pages 172-178

  Vanderheyden, Marc ^a   Mullens, Wilfried ^a   Delrue, Leen ^a   Goethals, Marc ^a   Verstreken, Sofie ^a   Wijns, William ^a   de Bruyne, Bernard ^a   Bartunek, Jozef ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

Author keywords

beta 1 adrenoreceptor; Cardiac resynchronization therapy; force frequency relation; myocardial contractile reserve

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DOBUTAMINE; ADRENERGIC RECEPTOR;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLASSIFICATION; CLINICAL ARTICLE; DRUG INFUSION; FEMALE; GENE EXPRESSION REGULATION; HEART BEAT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART PACING; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR GENE; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; ENDOCARDIUM; EXERCISE TOLERANCE; FORWARD HEART FAILURE; GENE EXPRESSION; GENETICS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; MIDDLE AGED; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; CARDIAC OUTPUT, LOW; CARDIAC PACING, ARTIFICIAL; DOBUTAMINE; ENDOCARDIUM; EXERCISE TOLERANCE; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MYOCARDIAL CONTRACTION; MYOCARDIUM; RECEPTORS, ADRENERGIC; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 39749173078     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.10.016     Document Type: Article

References (24)

1. Alpert N.R., Leavit B.J., Ittleman F.P., Hasenfuss G., Pieske B., and Mulieri L.A. A mechanistic analysis of the force-frequency relation in non-failing and progressively failing human myocardium. Basic Res Cardiol 93 Suppl 1 (1998) 23-32
2. Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
3. Linde C., Leclercq C., Rex S., Garrigue S., Lavergne T., Cazeau S., et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40 (2002) 111-118
4. Leclercq C., and Kass D.A. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 39 (2002) 194-201
5. Breithardt O.A., Sinha A.M., Schwammenthal E., Bidaoui N., Markus K.U., Franke A., et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 41 (2003) 765-770
6. Steendijk P., Tulner S.A., Bax J.J., Oemrawsingh P.V., Bleeker G.B., van Erven L., et al. Hemodynamic effects of long-term cardiac resynchronisation therapy. Circulation 113 (2006) 1295-1304
7. Glick G., Sonnenblick E.H., and Braunwald E. Myocardial force-velocity relations studied in intact unanesthetized man. J Clin Invest 44 (1965) 978-988
8. Bowditch H.P. Über die Eigenthümlichkeiten der Reizbarkeit, welche Muskelfasern des Herzens zeigen. Ber Sachs Ges Wiss 23 (1871) 652-689
9. Mulieri L.A., Hasenfuss G., Leavitt B., Allen P.D., and Alpert N.R. Altered myocardial force-frequency relation in human heart failure. Circulation 85 (1992) 1743-1750
10. Brodde O.E. β-Adrenoceptors in cardiac disease. Pharmacol Ther 60 (1993) 405-430
11. Bhargava V., Shabetai R., Mathiasen R.A., Dalton N., Hunter J.J., and Ross Jr. J. Loss of adrenergic control of the fore-frequency relation in heart failure secondary to idiopathic or ischemic cardiomyopathy. Am J Card 81 (1998) 1130-1137
12. Penicka M., Bartunek J., De Bruyne B., Vanderheyden M., Goethals M., De Zutter M., et al. Improvement of left ventricular function after cardiac resynchronisation therapy is predicted by tissue doppler imaging echocardiography. Circulation 109 (2004) 978-983
13. Daubert J.C., Ritter P., Le Breton H., Gras D., Leclercq C., Mugica J., et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 21 (1998) 239-245
14. van Gelder B.M., Bracke F.A., Meijer A., Lakerveld L.J.M., and Pijls N.H.J. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol 93 (2004) 1500-1503
15. Feldman A.M., Ray P.E., Silan C.M., Mercer J.A., Minobe W.A., and Bristow M.R. Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation 83 (1991) 1866-1872
16. Vollman D., Luthje L., Schott P., Hasenfuss G., and Unterberg-Buchwald C. Biventricular pacing improves the blunted force-frequency relation present during univentricular pacing in patients with heart failure and conduction delay. Circulation 113 (2006) 953-959
17. Mullens W., Bartunek J., Tang W.H., Delrue L., Herbots L., Willems R., et al. Early and late effects of cardiac resynchronization therapy upon force-frequency relation and contractility regulating gene expression in heart failure patients. Heart Rhythm 5 (2008) 52-59
18. Trautwein W., and Hescheler J. Regulation of cardiac L-type calcium current by phosphorylation and G proteins. Annu Rev Physiol 52 (1990) 257-274
19. Sasaki T., Inui M., Kimura Y., Kuzuya T., and Tada M. Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. J Biol Chem 267 (1992) 1674-1679
20. Brodde O.E., and Michel M.C. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51 (1999) 651-689
21. Bristow M.R., Ginsburg R., Minobe W., Cubicciotti R.S., Sageman W.S., Lurie K., et al. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307 (1982) 205-211
22. Ungerer M., Bohm M., Elce J.S., Erdmann E., and Lohse M.J. Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 87 (1993) 454-463
23. Najem B., Unger P., Preumont N., Jansens J.L., Houssiere A., Pathak A., et al. Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders. Am J Physiol Heart Circ Physiol 291 (2006) H2647-H2652
24. Mahler F., Ross Jr. J., O'Rourke R.A., and Covell J.W. Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. Am J Cardiol 35 (1975) 626-634